Newly Combined Zimmer Biomet Announces Leadership, Organizational Structure
Zimmer Holdings on Thursday announced the executive team that will lead the company following its $13.35 billion acquisition of Biomet, expected to close in the first quarter of next year. The combined companies will be renamed Zimmer Biomet, leveraging the strength and name-recognition of both firms’ brands, Zimmer said.
David Dvorak, president and CEO of Zimmer, will continue in those roles for the combined company. The company will be organized around three business units operating in three geographic regions: the Americas; Europe, the Middle East and Africa; and the Asia Pacific region.
Heading up the business units will be: Adam Johnson, group president for spine, microfixation, bone healing and dental products; David Nolan, group president for sports medicine, extremities, trauma, biologics and surgical devices; and Daniel Williamson, group president for knee, hip and bone cement products.
The two Warsaw, Ind., companies agreed to the merger on April 24, making the combined company the second largest in the musculoskeletal device market behind Johnson & Johnson. — Kellen Owings
Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.